Interactions between alkylglycerols and human neutrophil granulocytes

References

• Horrocks L A. Content, composition and metabolism of mammalian lipids that contain ether groups. Ether Lipids, F Snyder. Academic Press, New York 1972; 177–272
   Google Scholar
• Mueller H W, Oflaherty J T, Greene D G, Samuel M P, Wykle R L. 1-O-alkyl-linked glycerophos-pholipids of human neutrophils: distribution of arachidonate and other acyl residues in the ether-linked and diacyl species. J Lipid Res 1984; 25: 383–8
   PubMed Web of Science ®Google Scholar
• Boeryd B, Nilsson T, Lindholm L, Langc S, Hallgren B, Ställberg G. Stimulation of immune reactivity by methoxy-substituted glycerol ethers incorporated into the feed. Eur J Immunol 1978; 8: 678–80
   PubMed Web of Science ®Google Scholar
• Herrmann B J, Neumann H A. Cytotoxic ether phospholipids. J Biol Chem 1986; 261: 7742–7
   PubMed Web of Science ®Google Scholar
• Hallgren B. Therapeutic effects of ether lipids. Academic Press, Ether Lipids, New York 1983; 270
   Google Scholar
• Croft S L, Neal R A, Pendergast W, Chant J H. The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani. Biochem Pharmacol 1987; 36: 2633–6
   PubMed Web of Science ®Google Scholar
• Brohult A, Brohult J, Brohult S. Effect of irradiation and alkoxyglycerol treatment on the formation of antibodies after Salmonella vaccination. Experientia 1972; 28: 954–5
   PubMedGoogle Scholar
• Unger C, Eibl H, Kim D J, et al. Sensitivity of leukemia cell lines to cytotoxic alkyllysophospho-lipids in relation to O-alkvl cleavage enzyme activities. J Natl Cancer Inst 1987; 78: 219–22
   PubMed Web of Science ®Google Scholar
• Andreesen R, Modolell M, Weitzien H U, et al. Selective destruction of human leukemic cells by alkyl-lysophospholipids. Cancer Research 1978; 78: 3894–9
   Google Scholar
• Brohult A, Brohult J, Brohult S, Joelsson I. Reduced mortality in cancer patients after administration of alkoxyglycerols. Acta Obstet Gynecol Scand 1986; 65: 779–85
   PubMed Web of Science ®Google Scholar
• Sisson J H, Prescott S M, McLntyre T M, Zimmerman G A. Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. J Immunol 1987; 138: 3918–26
   PubMed Web of Science ®Google Scholar
• Goetzl E J, Derian C K, Tauber A I, Valone F H. Novel effects of 1-O-hexadecyl-2-acyl-in-glycero-3-phosphorlycholine mediators on human leukocyte function: delineation of the specific roles of the acyl substituents. Biochem Biophys Res Commun 1980; 94: 881–8
   PubMed Web of Science ®Google Scholar
• Vercellotti G M, Yin H O, Gustafson K S, Nelson R D, Jacob H S. Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage. Blood 1988; 71: 1100–7
   PubMed Web of Science ®Google Scholar
• Naccache P H, Molski M M, Volpi M, et al. Biochemical events associated with the stimulation of rabbit neutrophils by platelet-activating factor.1. Leukocyte Biol 1996; 40: 533–48
   Google Scholar
• Nilsson E, Palmblad J. Effects of ethanol on mechanisms for secretory and aggregatory responses of human granulocytes. Biochcm Pharmacol 1988; 37: 3237–43
   PubMed Web of Science ®Google Scholar
• Ringertz B, Palmblad J, Rådmark O, Malmsten C. Leukotriene-induced neutrophil aggregation in vitro. FEBS Letters 1982; 147: 180–2
   PubMed Web of Science ®Google Scholar
• Palmblad J, Gyllenhammar H, Lindgren J Å, Malmsten C. Effects of leukotrienes and f-met-leu-phe on oxidative metabolism of neutrophils and eosinophils. J Immunol 1984; 132: 3041–5
   PubMed Web of Science ®Google Scholar
• Gyllenhammar H. Mechanisms for luminol-augmented chemiluminescence from neutrophils induced by leukotriene B4 and N-formyl-methionyl-leucyl-phenylalaninc. Photochcm Photo-biol 1989; 49: 217–23
   PubMed Web of Science ®Google Scholar
• Palmblad J, Gyllenhammar H, Ringertz B, Nilsson E, Cottell B. Leukotriene B4 triggers highly characteristic and specific functional responses in neutrophils: studies of stimulus specific mechanisms. Biochem Biophys Acta 1988; 970: 92–102
   Google Scholar
• Metcalf J A, Gallin J I, Nauseef W M, Root R K. Laboratory Manual of Neutrophil Function. Raven Press, New York 1986
   Google Scholar
• Poitevin B, Roubin R, Benveniste J. PAF-acether generates chc Miluminescence in human neutrophils in the absence of cytochalasin B. Immuno-pharmacology 1984; 7: 135–44
   PubMed Web of Science ®Google Scholar
• DahlgrenCStendahl O. Role of myeloperoxidase in lumino-dependent chemiluminescence of polymorphonuclear leukocytes. Infect Immun 1983; 39: 736–41
   PubMed Web of Science ®Google Scholar
• Dahlgren C, Stendahl O. Effect of in vitro preincubation of polymorphonuclear leukocytes on formyl-methionyl-leucyl-phenylalanine induced chemiluminescence. Infect Immun 1982; 37: 34–9
   PubMed Web of Science ®Google Scholar
• Gyllenhammar H. Correlation between neutrophil superoxide formation, luminol-augmented chemiluminescence and intracellular Ca2+ levels upon stimulation with leukotriene B4, formylpeptide and phorbolcster. Scand J Clin Lab Invest 1989; 49: 317–22
   PubMed Web of Science ®Google Scholar
• Lew D, Monod A, Waldvogel F A, Pozzan T. Role of cytosolic free calcium and phospholipase C in leukotriene-B4-stimulated secretion in human neutrophils. Eur J Biochem 1987; 162: 161–8
   PubMedGoogle Scholar
• Dewald B, Baggiolini M. Activation of NADPH oxidase in human neutrophils. Synergism between fMLP and the neutrophil products PAF and LTB4. Biochem Biophys Res Commun 1985; 128: 297–304
   PubMed Web of Science ®Google Scholar
• Gay J C, Beckman J K, Zaboy K A, Lukens J N. Modulation of neutrophil oxidative responses to soluble stimuli by platelet-activating factor. Blood 1986; 67: 931–6
   PubMed Web of Science ®Google Scholar
• Berdel W E, von Hoff D D, Unger C, et al. Ether lipid derivatives: antineoplastic activity in vitro and the structure-activity relationship. Lipids 1986; 21: 301–4
   PubMed Web of Science ®Google Scholar
• Englberger W, Bitter-Suermann D, Hadding U. Influence of lysophospholipids and PAF on the oxidative burst of PMNL. Int J Immunopharmacol 1987; 9: 275–82
   PubMed Web of Science ®Google Scholar
• Apfeldorf W J, Melnick D A, Meshulam T, Rasmussen H, Malech H L. A transient rise in intracellular free calcium is not a sufficient stimulus for respiratory burst activation in human polymorphonuclear leukocytes. Biochem Biophys Res Commun 1985; 132: 674–80
   PubMed Web of Science ®Google Scholar
• O'Flaherty J T, Nishihira J. Arachidonate metabolites, platelet-activating factor, and the mobilization of protein kinase C in human polymorphonuclear neutrophils. J Immunol 1987; 138: 1889–95
   PubMed Web of Science ®Google Scholar
• Daniel L W, Small G W, Schmitt J D. Alkyl-linked diglycerides inhibit protein kinase C activation by diacylclycerols. Biochem Biophys Res Commun 1988; 151: 291–7
   PubMed Web of Science ®Google Scholar
• Glasser L, Somberg L B, Vogler W R. Purging murine leukemic marrow with alkyllysophospho-lipids. Blood 1984; 64: 1288–91
   PubMed Web of Science ®Google Scholar
• Brohult A. Alkoxyglycerols and their use in radiation treatment. Acta Radiologica 1963, Suppl. 223: 7–99
   Google Scholar